Mufg Securities Americas Inc. Makes New Investment in Molina Healthcare, Inc. (NYSE:MOH)

Mufg Securities Americas Inc. bought a new position in shares of Molina Healthcare, Inc. (NYSE:MOH) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 845 shares of the company’s stock, valued at approximately $246,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MOH. Norges Bank bought a new position in Molina Healthcare during the fourth quarter worth about $134,675,000. FMR LLC boosted its position in Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company’s stock worth $524,214,000 after purchasing an additional 427,276 shares during the period. Invesco Ltd. boosted its position in Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company’s stock worth $386,229,000 after purchasing an additional 294,180 shares during the period. Wellington Management Group LLP boosted its position in Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company’s stock worth $766,111,000 after purchasing an additional 181,073 shares during the period. Finally, Los Angeles Capital Management LLC boosted its position in Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock worth $57,195,000 after purchasing an additional 122,674 shares during the period. Institutional investors own 98.50% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on MOH. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 price objective for the company. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, April 11th. Robert W. Baird restated a “neutral” rating and issued a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. UBS Group cut their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research report on Friday, February 7th. Finally, Guggenheim began coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating for the company. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $365.38.

Molina Healthcare Trading Up 3.5%

Shares of Molina Healthcare stock opened at $325.02 on Friday. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The firm has a market cap of $17.62 billion, a PE ratio of 15.91, a PEG ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The company has a 50 day simple moving average of $324.07 and a two-hundred day simple moving average of $308.43.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same period in the previous year, the business posted $5.73 earnings per share. Molina Healthcare’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Transactions at Molina Healthcare

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of the business’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares of the company’s stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is currently owned by insiders.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.